Autoimmune Thrombocytopenia in SLE and COVID-19

European Journal of Case Reports in Internal Medicine

RiskaPradiptakirana¹  Yeremia Suryo Pratama¹  Azkia Rachmah¹  Nurhasan Agung Prabowo² 

[1] Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia;Internal Medicine Department, Faculty of Medicine, Sebelas Maret University Hospital, Surakarta, Indonesia;

关键词: covid-19;    hypercoagulopathy;    sle;    thrombocytopenia;   

DOI  :  10.12890/2021_002863

来源: DOAJ

【 摘 要 】

Thrombocytopenia and hypercoagulopathy are haematological abnormalities commonly seen in individuals with coronavirus disease 2019 (COVID-19) and systemic lupus erythematosus (SLE). The difficulty arises when the patient has both diseases concurrently. The clinician should be able to comprehend the pathophysiology of these patient abnormalities in order to provide the best treatment possible. We present a case of a 20-year-old female COVID-19 patient with a history of SLE who had thrombocytopenia but normal D-dimer results. Our analysis revealed that the thrombocytopenia may have been caused by a relapse of lupus, not by COVID-19 infection. In this case, glucocorticoids were the primary therapy and produced excellent results.

【 授权许可】

Unknown